PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Mind Medicine (MindMed) Inc. (MNMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCA60255C1095
CUSIP60255C109
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$665.54M
EPS-$2.44
PEG Ratio-0.94
EBITDA (TTM)-$80.93M
Year Range$2.41 - $12.22
Target Price$30.86
Short %9.88%
Short Ratio2.84

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Mind Medicine (MindMed) Inc.

Popular comparisons: MNMD vs. CMPS, MNMD vs. GOOG, MNMD vs. QQQ

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Mind Medicine (MindMed) Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%December2024FebruaryMarchAprilMay
-68.63%
139.47%
MNMD (Mind Medicine (MindMed) Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Mind Medicine (MindMed) Inc. had a return of 130.87% year-to-date (YTD) and 176.14% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date130.87%10.00%
1 month-12.62%2.41%
6 months247.74%16.70%
1 year176.14%26.85%
5 years (annualized)10.15%12.81%
10 years (annualized)N/A10.84%

Monthly Returns

The table below presents the monthly returns of MNMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20245.46%48.06%64.48%1.28%130.87%
202355.00%9.09%-14.78%20.50%-7.33%0.85%38.10%-15.82%-24.58%-18.21%28.91%10.91%66.36%
2022-18.84%8.93%-9.02%-27.93%13.09%-29.25%8.53%12.47%-70.14%-16.29%-12.97%-13.73%-89.37%
2021-3.30%12.56%-15.98%40.17%-13.04%1.47%-11.30%-5.56%-19.38%8.15%-21.43%-30.30%-54.75%
2020-10.71%0.00%40.00%-19.64%-11.72%-6.36%-14.33%14.85%63.19%29.47%114.11%84.21%580.80%
201912.76%4.74%12.48%12.46%-18.06%11.11%-83.33%371.00%8.49%29.55%-27.95%17.40%26.96%
2018-22.90%-37.60%7.85%-2.73%0.07%-40.27%-20.42%40.77%-16.21%2.38%-37.28%-18.31%-85.15%
201722.06%52.18%-18.01%-28.59%-14.57%0.94%-3.26%-23.96%-6.27%-20.75%-2.24%8.00%-45.89%
201654.57%58.18%144.50%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of MNMD is 88, placing it in the top 12% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of MNMD is 8888
MNMD (Mind Medicine (MindMed) Inc.)
The Sharpe Ratio Rank of MNMD is 9090Sharpe Ratio Rank
The Sortino Ratio Rank of MNMD is 9090Sortino Ratio Rank
The Omega Ratio Rank of MNMD is 8484Omega Ratio Rank
The Calmar Ratio Rank of MNMD is 9090Calmar Ratio Rank
The Martin Ratio Rank of MNMD is 8787Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Mind Medicine (MindMed) Inc. (MNMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MNMD
Sharpe ratio
The chart of Sharpe ratio for MNMD, currently valued at 1.86, compared to the broader market-2.00-1.000.001.002.003.001.86
Sortino ratio
The chart of Sortino ratio for MNMD, currently valued at 2.93, compared to the broader market-4.00-2.000.002.004.006.002.93
Omega ratio
The chart of Omega ratio for MNMD, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for MNMD, currently valued at 1.76, compared to the broader market0.002.004.006.001.76
Martin ratio
The chart of Martin ratio for MNMD, currently valued at 7.30, compared to the broader market-10.000.0010.0020.0030.007.30
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.35, compared to the broader market-2.00-1.000.001.002.003.002.35
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.33, compared to the broader market-4.00-2.000.002.004.006.003.33
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.90, compared to the broader market0.002.004.006.001.90
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.02, compared to the broader market-10.000.0010.0020.0030.009.02

Sharpe Ratio

The current Mind Medicine (MindMed) Inc. Sharpe ratio is 1.86. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Mind Medicine (MindMed) Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2024FebruaryMarchAprilMay
1.86
2.28
MNMD (Mind Medicine (MindMed) Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Mind Medicine (MindMed) Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-94.37%
-0.63%
MNMD (Mind Medicine (MindMed) Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Mind Medicine (MindMed) Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Mind Medicine (MindMed) Inc. was 99.99%, occurring on Dec 26, 2019. The portfolio has not yet recovered.

The current Mind Medicine (MindMed) Inc. drawdown is 94.37%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.99%Mar 20, 2017512Dec 26, 2019
-19.58%Jan 24, 201711Feb 8, 20174Feb 16, 201715
-13.43%Jan 5, 20172Jan 6, 20172Jan 11, 20174
-10.37%Mar 3, 20171Mar 3, 20172Mar 7, 20173
-8.04%Mar 8, 20175Mar 14, 20171Mar 15, 20176

Volatility

Volatility Chart

The current Mind Medicine (MindMed) Inc. volatility is 19.61%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2024FebruaryMarchAprilMay
19.61%
3.61%
MNMD (Mind Medicine (MindMed) Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Mind Medicine (MindMed) Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items